Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States.
Last updated on
About Milestone Pharmaceuticals
Founded
2005Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$288MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
MontrealState
QuebecCountry
CanadaTech Stack (90)
Devops And Development
Programming Languages And Frameworks
Communications
Platform And Storage
Business Intelligence And Analytics
IT Security
Sales
Product And Design
E-commerce
IT Management
Finance And Accounting
HR
Widgets
Yoast Plugins
Font Awesome
WPML Multilingual
WPBakery
Cloudflare Bot Manager
Google Font API
Wordpress Plugins
Sitelinks Search Box
Twemoji
Contact Form 7
Slider Revolution
Visual Composer Ultimate Addons
ThemePunch
Typekit
PhotoSwipe
99Robots HFCM
Quick Page Post Redirect Plugin
Popup Maker for Wordpress
Google Tag Manager
Draftpress HFCM
WordPress Zero Spam
US Privacy User Signal Mechanism
CrUX Dataset